HCPLive Network

Genetic Variations Confer Risk for Multiple Psychiatric Disorders

THURSDAY, Feb. 28 (HealthDay News) -- Specific single nucleotide polymorphisms (SNPs) seem to confer risk of a diverse set of psychiatric disorders, according to a study published online Feb. 28 in The Lancet.

Jordan W. Smoller, MD, from Massachusetts General Hospital, in Boston, and colleagues from the Cross-Disorder Group of the Psychiatric Genomics Consortium examined genome-wide SNP data for autism spectrum disorder, attention-deficit/hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia in 33,332 cases and 27,888 controls of European ancestry. The allelic effects of each disorder were characterized.

In the primary analysis the researchers found that SNPs at four loci (regions on chromosomes 3p21 and 10q24 and within two L-type voltage-gated calcium channel subunits) exceeded the cut-off for genome-wide significance. The effects of these loci were supported for several disorders. Variable diagnostic specificity was seen for loci previously associated with bipolar disorder or schizophrenia. Based on polygenic risk score analysis there were cross-disorder associations, particularly between disorders with adult onset. For all five disorders, pathway analysis supported a role for genes in calcium channel signaling. Enrichment of brain-tissue expression quantitative trait loci was seen in SNPs with evidence of cross-disorder association.

"Our findings show that specific SNPs are associated with a range of psychiatric disorders of childhood onset or adult onset," the authors write. "These results provide evidence relevant to the goal of moving beyond descriptive syndromes in psychiatry, and towards a nosology informed by disease cause."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Hospital conversion to for-profit status is associated with improvements in financial margins, but has no effect on process quality metrics or mortality rates, according to a study published in the Oct. 22/29 issue of the Journal of the American Medical Association
Drug coupons could reduce patients' out-of-pocket costs by 60 percent, according to a study published in the October issue of Health Affairs.
Depressive symptoms are associated with poorer long-term outcome in patients undergoing surgery for lumbar spinal stenosis (LSS), according to research published in the Oct. 1 issue of The Spine Journal.
Maternal eating disorders are associated with adverse pregnancy, obstetric, and perinatal health outcomes, according to a study published in the October issue of the American Journal of Obstetrics & Gynecology.
Access to an employer-sponsored private price transparency platform is associated with reduced total claims payments, according to research published in the Oct. 22/29 issue of the Journal of the American Medical Association.
Medications commonly used to treat Parkinson's disease may raise the risk of impulse control disorders such as compulsive gambling, compulsive shopping, and/or hypersexuality, according to a new review published online Oct. 20 in JAMA Internal Medicine.
A state law that requires plaintiffs to release relevant protected health information before proceeding with allegations of medical liability has been upheld by a federal appeals court, according to the American Medical Association.
More Reading